A cluster randomized controlled trial on the effects and costs of advance care planning in elderly care: Study protocol by Korfage, I.J. (Ida) et al.
STUDY PROTOCOL Open Access
A cluster randomized controlled trial on the
effects and costs of advance care planning
in elderly care: study protocol
Ida J. Korfage1*†, Judith A.C. Rietjens1*†, Anouk Overbeek1, Lea J. Jabbarian1, Pascalle Billekens2,
Bernard J. Hammes3, Ellen Hansen-van der Meer2, Suzanne Polinder1, Johan Severijnen2, Siebe J. Swart2,
Frederika E. Witkamp1 and Agnes van der Heide1
Abstract
Background: Currently, health care and medical decision-making at the end of life for older people are often
insufficiently patient-centred. In this trial we study the effects of Advance Care Planning (ACP), a formalised process
of timely communication about care preferences at the end of life, for frail older people.
Methods/Design: We will conduct a cluster randomised controlled trial among older people residing in care
homes or receiving home care in the Netherlands. The intervention group will receive the ACP program Respecting
Choices® in addition to usual care. The control group will receive usual care only. Participants in both groups will fill
out questionnaires at baseline and after 12 months. We hypothesize that ACP will lead to better patient activation
in medical decision making and quality of life, while reducing the number of medical interventions and thus health
care costs. Multivariate analysis will be used to compare differences between the intervention group and the
control group at baseline and to compare differences in changes after 12 months following the inclusion.
Discussion: Our study can contribute to more understanding of the effects of ACP on patient activation and
quality of life in frail older people. Further, we will gain insight in the costs and cost-effectiveness of ACP. This study
will facilitate ACP policy for older people in the Netherlands.
Trial registration: Nederlands Trial Register: NTR4454.
Keywords: Advance care planning, Advance directives, Respecting choices, Elderly care, Cost-effectiveness,
Quality of life, Patient activation
Background
The number of Europeans over 65 years of age will
double in the next 50 years. To enable countries to suc-
cessfully manage the dynamics and health care costs of
their ageing populations, the WHO has proposed an
“active ageing approach”, based on the United Nations
Principles of independence, participation, dignity, care
and self-fulfillment [1]. It targets government decision-
makers at all levels, the nongovernmental sector and the
private sector, all of whom are responsible for the
formulation of policies and programs on ageing. It fo-
cuses on the activation of older people and is aimed at
timely recognition and consideration of people’s health
care preferences and needs to enable strategic planning
and decision-making by older people themselves. Com-
munication about people’s needs and preferences is
typically postponed until acute events necessitate short-
term medical decision-making. Sharp et al. showed that
the majority of frail, older people would like to get the
opportunity to timely discuss end-of life care. However,
most of them do not have this opportunity [2].
Advance Care Planning (ACP) is a formalised process of
communication between patients, their relatives and pro-
fessional caregivers about patients’ health preferences,
goals and choices [3]. Its central aim is to activate people
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to participate in decision-making about their health care
and to raise awareness of the need to anticipate future de-
terioration of health. Patients are encouraged to appoint a
surrogate decision-maker, and to document their wishes
about their preferred care in an advance directive. In this
way, written advance directives extend the autonomy of
patients to a phase when they are incompetent [4].
Several studies have assessed the outcomes of ACP pro-
grams. In der Schmitten et al. studied the effects of imple-
menting a regional ACP program in German nursing
homes and concluded that the implementation led in
many cases to the completion of advance directives with
potential relevance to medical decision-making [5]. Some
reviews showed that ACP is associated with better patient
outcomes. In a recent systematic review, Brinkman-
Stoppelenburg et al. showed that some ACP programs are
associated with a reduction in futile measures and un-
necessary hospitalizations [6]. The programs contributed
to better communication between patients and health care
professionals and higher quality of life of both patients
and their relatives. Furthermore, extensive ACP inter-
ventions seemed to increase compliance with patient
wishes and satisfaction with care more than just the com-
pletion of advance directives. According to the review of
Brinkman-Stoppelenburg et al. extended programs such
as e.g. the Respecting Choices program are the most
promising ACP programs [6]. In another systematic re-
view, Houben et al. showed that ACP programs facilitated
completion of advance directives and end-of-life discus-
sions between patients and health care professionals. The
programs improved concordance between preferred and
delivered care and potentially improve other outcomes as
well, such as quality of communication [7].
Overall, we can conclude that ACP programs have
beneficial effects on several patient outcomes. However,
evidence on the effects of ACP programs in care homes
and in community dwelling older people is scarce [6, 7].
Furthermore, few studies concerned a randomized con-
trolled trial, although this is the most preferred method
of studying effects of interventions in health care. Fi-
nally, most of the studies were performed in the US. Pre-
vious research showed that end-of-life decision-making
varies largely between countries [8]. It is unknown to
what extent results from the US can be generalized to
European countries like the Netherlands, given the dif-
ferences in health care systems.
Also, research on the costs of ACP is limited, although
the cost-effectiveness of health care interventions at the
end of life is an important issue due to the fact that end-
of-life care is often expensive. While health care costs in
an average life year have been found to amount to 1100 €
per person, costs per last year of life were 13,5 times
higher and approximated 14,900 € per person according
to Polder et al. [9]. Molloy et al. assessed the costs of an
ACP program in a randomized controlled trial in Ontario,
Canada. Intervention nursing homes reported fewer
hospitalizations per resident, a lower hospital length of
stay ensuing reduced hospital care costs and lower total
health care costs than control nursing homes [10]. We
are not aware of any formal cost-effectiveness studies
on ACP programs in care homes or nursing homes in
Europe.
We will perform the first cluster randomized con-
trolled trial on the effects of ACP in frail, older people
in the Netherlands. The main objective of this project is
to assess the effects, the costs and the cost-effectiveness
of ACP. Participants in the intervention group will be of-
fered the Respecting Choices program, one of the most
promising ACP programs (see below for further infor-
mation about the program) [6, 11]. We focus on older
people living in care homes or living at home and receiv-
ing home care. We hypothesize that ACP will lead to
better patient activation in medical decision making and
quality of life in the intervention group compared to the
control group, while reducing futile interventions and
thus health care costs.
Methods/Design
Study design
We will conduct a cluster Randomized Controlled Trial
(RCT) among older people living in care homes or at
home receiving home care, following the CONSORT
guidelines. The clusters will consist of neighbourhoods.
In the Netherlands, standardized household incomes
have been calculated per neighbourhood. We will order
neighbourhoods according to these standardized in-
comes to control for differences in income per study
arm, since income is related to health [12]. Neighbour-
hoods will be randomized per set of two neighbourhoods
with comparable household incomes to either the con-
trol or intervention condition.
Study population
The study population consists of older people living at
home and receiving home care or residing in one of 16
participating care homes of Laurens, a care organisation
in Rotterdam, the Netherlands. Residents of care homes
generally suffer from one or more chronic conditions
and 32 % are totally dependent on others for daily care
needs [13]. Their average life expectancy is 3,7 years,
and their health condition often involves important
health care decisions in a relatively short time frame.
Inclusion criteria
In order to be eligible to participate in this study, an
older person must meet all of the following criteria:
1. ≥75 years of age;
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2. Mentally competent, as measured by judgement of
caregiver and a Mini–Mental State Examination
(MMSE score > 16 [14];
3. Fluent in Dutch;
4. Being frail, as measured by the Tilburg Frailty Index
[15] (TFI score of 5 or more)
These criteria apply for both people living in care
homes and people living at home and receiving home
care. Older people who move during the follow-up of
the study can remain included in the study.
Intervention
Older people in the intervention group will be offered
the Respecting Choices program in addition to their
usual care. This program, developed in the US, involves
trained nurse facilitators who, in collaboration with phy-
sicians, assist residents and their relatives in reflecting
on the resident’s goals, values and beliefs and in discuss-
ing their health care wishes [11, 16]. This discussion also
supports people to identify specific activities and experi-
ences that may contribute to, or detract from, their qual-
ity of life. Residents are encouraged to appoint a
surrogate decision-maker, and to document their wishes
about the care they do or do not want to receive in an
advance directive. These wishes can e.g. concern the
(non)use of burdensome life-prolonging interventions
such as hospitalization or cardio-pulmonary resuscita-
tion. For our study, a nurse practitioner followed the Re-
specting Choices train-the-facilitators program in the
US. She will deliver the training program for the facilita-
tors. These are nursing staff members of Laurens, who
will deliver the intervention to the study participants.
The intervention concerns two meetings of a facilitator
with a participant of 1 h. The content of the communi-
cation during these meetings will be structured by the
use of interview cards.
Primary and secondary outcomes
The primary outcome measure is patient activation,
which measures patient participation in medical decision
making [17]. Secondary outcome measures are quality of
life, satisfaction with health care, cost-effectiveness, use
of burdensome medical interventions, appointment of a
surrogate decision- maker and documentation of care
wishes in advance directives.
Assessment and data collection
At baseline, in personal structured interviews, patient
activation will be measured (PAM-13) [17]. The PAM
assesses patients’ knowledge, skill and confidence in
self- management. Also, generic Health-Related Quality
of Life as measured by the SF-12 [18] and satisfaction
with health care as measured by the PSQ-18-SF6 [19]
will be assessed.
At 12 month follow-up participants will be inter-
viewed again and their competence will be assessed
with an adapted version of the Mini-Cog [20]. If partici-
pants are competent, the questions of the SF-12 [18],
PAM [17], and PSQ-18-SF6 [19] will be asked. We will
also ask whether participants completed an advance
directive and assigned a proxy decision-maker. In the
intervention group, open (qualitative) questions will be
asked about how the patient experienced the ACP
program.
If the Mini-Cog indicates that participants are no lon-
ger competent, a proxy, assigned by the patient at the
start of the study, will be approached for a telephone
interview. This interview will include the PSQ-18-SF6
[19] and a caregiver activation measure (CAM) [21].
Completion of an advance directive and assignment of a
proxy decision-maker by the participant will be assessed.
In the intervention group, open (qualitative) questions
will be asked about how the relative and the patient ex-
perienced the ACP program.
If people pass away during the 12 month follow-up, a
proxy, assigned by the patient at the start of the study,
will be approached for a telephone interview. This inter-
view will address characteristics of the dying process,
quality of dying [16], PSQ-18-SF6 [19], feelings of anx-
iety and depression of the relative as measured by the
HADS [22]. In the intervention group, open (qualitative)
questions will be asked about how the relative and the
patient experienced the ACP program.
In a medical file study, we will investigate whether
people have an advance directive in their medical file
(and study its content). Moreover, we will study the
medical care people receive during 12 months after in-
clusion, such as hospitalizations (number, length of
stay), use of homecare, palliative care, diagnostic proce-
dures and specific treatments (e.g. medication, mechan-
ical ventilation, resuscitation, chemotherapy, artificial
fluids or food, surgery or antibiotics).
Furthermore, an extensive economic evaluation of
ACP will be performed from a health care perspective.
For the calculation of the health care costs we will dis-
tinguish intramural and extramural medical costs. The
unit price of the ACP program will be determined
with the micro-costing method, which is based on a
detailed assessment of all resources used [23]. There-
fore, ACP facilitators will register their time invest-
ments per individual participant. Costs for inpatient
days in care homes will be estimated as real, basic
costs per day using detailed administrative informa-
tion. For the calculation of other medical costs, we
will use charges as published in Dutch guidelines as a
proxy of real costs [24].
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Sample size
We aim at an overall power of 0.8 (alpha 0.05) to detect
a difference of at least 0,5 SD in the Patient Activation
Measure. We consider 0,5 SD to be a clinical relevant
difference based on the article of Norman et al. [25]. To
be able to detect such a difference we need 63 individ-
uals in each arm in a non-clustered study. We used a
multiplication factor of (1 + (k-1)*ICC), with k indicating
the average cluster size, which is 12, and ICC indicating
the intraclass correlation, which is the fraction of total
variation in the data that is accounted for by between-
group variation. For an ICC of 0.05 this amounts to a
multiplication factor of 1.55, and thus 98 (1.55*63) indi-
viduals in both the intervention and the control arm.
Study procedures
Staff of the care organisation will use a checklist to as-
sess whether participants - either living in care homes or
at home - are potentially eligible for the study (see Fig. 1:
CONSORT Flow chart). These people will be informed
about the study and will be asked to participate by the
research team. Furthermore, in the intervention group
they will be invited to visit an informative meeting about
the study and the intervention.
People who express an interest in the study, will be
interviewed face-to-face by one of the researchers (AO,
LJ). During this interview, they will receive additional in-
formation about the study. When individuals fulfil the
inclusion criteria of the study and want to participate,
written informed consent will be obtained. Subsequently,
the baseline assessment will be completed and the inter-
vention will be carried out in the intervention group. At
12 months after inclusion in the study, participants will
be approached again by the researcher to complete a
face-to face follow-up assessment. With written per-
mission of the participants, data will be extracted from
medical files with the use of a checklist, 12 months post-
inclusion.
The independent Ethics committee of Rotterdam
(Medisch Ethische Toetsingscommissie) has given ap-
proval for the study to be performed.
Statistical analysis
Analyses will be performed following the intention-to-
treat principle. Descriptive statistics will be used to
summarize characteristics of the residents, the care
homes and of people receiving home care. Characte-
ristics of participating individuals (age, gender, socio-
Potential candidates are invited
to participate
Potential candidates are invited
to participate
Candidates are invited to
assess eligibility in personal
interview by researcher
Candidates are invited to
assess eligibility in personal
interview by researcher
Participants receive /
decline intervention
Excluded by team coordinator: Inclusion
criteria not met
Not participating
- No interest
- Died or moved to another home
- No response
Excluded by team coordinator: Inclusion
criteria not met
Not participating
- No interest
- Died or moved to another home
- No response
12-months follow-up
assessment
12-months follow-up
assessment
Included in before-after
analysis
Included in before-after
analysis
Team coordinators evaluate all
patients
Team coordinators evaluate all
patients
Participation Participation
Excluded by researcher: Inclusion criteria
not met
Excluded by researcher: Inclusion criteria
not met
Lists of potential care homes
N = 8 care homes
(including patients receiving
home care) are allocated to
intervention group
N = 8 care homes
(including patients receiving
home care) are allocated to
control group
Randomisation
Lost to follow-upLost to follow-up
Fig. 1 CONSORT flow chart
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economic status, educational level) will be compared at
baseline between the intervention and control (usual
care) group using independent sample t tests and Chi2
tests.
Multivariate analysis will be used to compare differ-
ences between the intervention group and the control
group at baseline and to compare differences in changes
after 12 months following the inclusion. Patient charac-
teristics, TFI score, MMSE score and place of residence
will be used as covariables. All statistical tests will be
considered significant if p < 0.05. Missing items will be
imputed by the peoples’ own average score if they have
completed at least 50 % of the items.
The cost-effectiveness of ACP will be assessed by cal-
culating the incremental cost-effectiveness ratio (ICER),
defined as the difference in costs of ACP compared to
usual care, divided by the average change in effective-
ness, with the patient activation as primary outcome
measure [17]. We will perform a sensitivity analysis to
assess the stability of the results to changes in costs and
effectiveness parameters. Because of the short time hori-
zon, costs and effects will not be discounted.
Discussion
The presented study measures the costs and effects of
ACP in elderly care. Until now, the costs and effects of
ACP in Dutch care homes have not been studied in a
randomized controlled trial. Currently, ACP is encour-
aged and several studies showed that ACP is associated
with beneficial effects on patient outcomes [6, 7]. How-
ever, we do not know whether these beneficial effects
apply to frail, older people residing in Dutch nursing
homes or living at home and receiving home care. The
presented study aims at studying whether offering ACP
to older people will improve patient activation, quality of
life and satisfaction with care, while reducing futile med-
ical interventions. Trained facilitators will talk with frail,
older people about their wishes and preferences con-
cerning medical treatment and care, facilitate timely
conversations between participants and their appointed
proxy decision-maker and support them in establishing
an advance directive. This study will contribute to the
implementation of an evidence-based ACP program for
older people in The Netherlands. Below, some strengths
and limitations of the study will be discussed.
Strengths and limitations
Strengths
First, older people will be offered standardized ACP
using the Respecting Choices program [11]. According
to Brinkman-Stoppelenburg et al., complex interventions
such as e.g. the Respecting Choices program are the
most promising ACP programs [6]. Second, this study
assesses costs. Until now no formal cost-effectiveness
studies of ACP programs in care homes or nursing
homes have been carried out. A methodological strength
is that we will conduct a cluster randomized control trial
which is the most preferred method of studying effects
of ACP. Due to this design we will be able to draw con-
clusions on causal relationships.
Limitations
First, selection bias in identifying potential study partici-
pants cannot be ruled out. To prevent this as much as
possible, we have prepared clear in and exclusion cri-
teria. These criteria are the same in both the interven-
tion arm and the control arm.
Second, follow-up of the respondents is limited to
12 months after inclusion, while the average life expect-
ancy of the study group is 3,7 years [13]. We expect that
respondents may need to make important health care
decisions within the timeframe of the study, given their
frailty, but we may miss important decisions. However,
the main goal of the study is to increase patient activa-
tion, and such activation is possible without major deci-
sions taking place. Examples of this are conversations
with relatives and health care professional about prefer-
ences regarding future care.
Third, dropout will be an inevitable limitation of the
study. Dropout can occur due to, for example, loss of
contact. However, we ask staff members of Laurens to
report participants moving house. If people move they
can remain included in the study. Dropout can also take
place because people are no longer interested in par-
ticipation. However, we expect that the number of drop-
outs will be similar in both groups. If participants die
during follow-up, one of their relatives will be asked to
complete a bereaved carer questionnaire.
Fourth, the extent to which medical files reflect actual
care can be questioned. We are not sure that all received
treatments will be written down in medical files.
Opportunities
Realization of the study will contribute to more under-
standing of the effects of ACP in older, frail people in
Europe. We will also gain insight in the costs and cost-
effectiveness of ACP, which has rarely been studied
until now. Positive outcomes of this study may facilitate
the implementation of ACP in the target population of
this study, but also in other populations and settings,
such as younger people and/or people with advanced
diseases. Future research could focus more on opinions
and experiences of the patient’s relatives. We hope that
our results will encourage debates and discussions
about optimal decision making in the last phase of life
and will lead to further studies, nationally and
internationally.
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